Results 111 to 120 of about 42,157 (238)

Atopy susceptibility and chromosome 19q13

open access: yes, 2010
We have replicated and further defined an atopy susceptibility locus on chromosome ...
Holloway, J.W., Sayers, I., Barton, S.J.
core   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Frequency, Burden and Pathogens of Acute Respiratory Illness in Very Preterm Infants During Infancy

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To describe the frequency, burden, and pathogen profile of acute respiratory illnesses (ARIs) in very preterm infants during the first year after neonatal intensive care unit (NICU) discharge. Methods Very preterm infants were followed prospectively (August 2015–January 2017) with monthly assessments of symptoms, medication use, and ...
Patricia De Gouveia Belinelo   +9 more
wiley   +1 more source

The problem of osteoarthritis in patients with atopy

open access: yesТерапевтический архив
The problem of osteoarthritis (OA) in patients with atopy (bronchial asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis) discussed. In patients with atopy, the risk of OA is significantly higher (36–58%) than in the general population.
Tatiana V. Beketova, Evgeny L. Nasonov
doaj   +1 more source

ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence

open access: yes, 2018
Samuel N Uwaezuoke,1 Joy N Eze,1 Adaeze C Ayuk,1 Ikenna K Ndu2 1Department of Paediatrics, University of Nigeria Teaching Hospital (UNTH), Ituku-Ozalla Enugu, Nigeria; 2Department of Paediatrics, Enugu State University Teaching Hospital, Enugu, Nigeria ...
Uwaezuoke SN, Eze JN, Ndu IK, Ayuk AC
core  

The benefits of multidisciplinary collaboration in the successful management of two complex feline cases

open access: yesAustralian Veterinary Journal, EarlyView.
Despite a frequent misconception that behavioural concerns are diagnoses of exclusion, medical conditions and behavioural disorders are frequently inter‐related. In human medicine, the ‘multidisciplinary team’ approach (MDTA) is considered the most efficacious way of managing patients with complex and chronic health conditions.
BE Bollaert, JM Ley, HE Zulch
wiley   +1 more source

Maternal atopy and parity

open access: yes, 2001
BACKGROUND: Family size and high birth order were related to the prevalence of hayfever and positive skin prick test. However, this association may be explained by maternal atopy.
Vall, O   +7 more
core  

A Real‐World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma

open access: yesClinical &Experimental Allergy, EarlyView.
Among patients with severe eosinophilic asthma, benralizumab was associated with greater improvements in asthma outcomes—such as improved asthma control, quality of life and remission rates—compared to biologic‐naïve patients. ABSTRACT Background Real‐world data on benralizumab in patients with severe eosinophilic asthma–while controlling for ...
Dennis Thomas   +23 more
wiley   +1 more source

TIM-4 Regulates Allergic Airway Inflammation and Mast Cell Activation by Binding to CD300b

open access: yesJournal of Asthma and Allergy
Yuki Tanabe,1,2 Fumitaka Kamachi,1 Jun Ito,2 Norihiro Harada,2 Sonoko Harada,2,3 Fumihiko Makino,2 Yoshiyuki Abe,4 Nobuhiro Nakano,3 Kumi Izawa,3 Francois Niyonsaba,3 Chiharu Nishiyama,5 Jiro Kitaura,3 Ko Okumura,1,3 Kazuhisa Takahashi,2 Hisaya Akiba,1 ...
Tanabe Y   +15 more
doaj  

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy